Canolfan ar gyfer Geneteg a Genomeg Niwroseiciatrig

2017 publications

Mae'r cynnwys hwn ar gael yn Saesneg yn unig.

Abdul Rahim, M. I. and Thomas, R. H. 2017. Gamification of medication adherence in epilepsy. Seizure - European Journal of Epilepsy 52 , pp.11-14. (10.1016/j.seizure.2017.09.008)
Absoud, M. et al., 2017. A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). Health Technology Assessment 21 31. (10.3310/hta21310)
Abu-Akel, A. et al., 2017. Autistic and schizotypal traits and global functioning in bipolar I disorder. Journal of affective disorders 207 , pp.268-275. (10.1016/j.jad.2016.09.059)
Adam, M. A. and Isles, A. R. 2017. EHMT1/GLP; biochemical function and association with brain disorders. Epigenomes 1 (3) 15. (10.3390/epigenomes1030015)
Agha, S. S. et al. 2017. Maternal psychopathology and offspring clinical outcome: a four-year follow-up of boys with ADHD. European Child and Adolescent Psychiatry 26 (2), pp.253-262. (10.1007/s00787-016-0873-y)
Al-Ansari, A. and Robertson, N. 2017. Creutzfeldt-Jacob disease: new directions in diagnosis and therapeutics. Journal of Neurology 264 (5), pp.1029-1031. (10.1007/s00415-017-8473-4)
Allardyce, J. et al. 2017. Psychosis and the level of mood incongruence in Bipolar Disorder are related to genetic liability for Schizophrenia. [Online].bioRxiv. Available at: http://dx.doi.org/10.1101/160119.
Andreassen, O. A. et al., 2017. Cortical abnormalities in bipolar disorder: An MRI analysis of 6,503 individuals from the ENIGMA-Bipolar Disorder Working Group. Molecular Psychiatry 23 , pp.932-942. (10.1038/mp.2017.73)
Antonakakis, M. et al., 2017. Reconfiguration of dominant coupling modes in mild traumatic brain injury mediated by δ-band activity: a resting state MEG study. Neuroscience 356 , pp.275-286. (10.1016/j.neuroscience.2017.05.032)
Bassett, A. S. et al., 2017. Rare genome-wide copy number variation and expression of schizophrenia in 22q11.2 deletion syndrome. American Journal of Psychiatry 174 (11), pp.1054-1063. (10.1176/appi.ajp.2017.16121417)
Benson, M. A. et al., 2017. Ryanodine receptors are part of the myospryn complex in cardiac muscle. Scientific Reports 7 (1) 6312. (10.1038/s41598-017-06395-6)
Bevan Jones, R. et al. 2017. Translation: From bench to brain – Using the visual arts and metaphors to engage and educate. Research for All 1 (2), pp.265-283. (10.18546/RFA.01.2.04)
Bevan-Jones, R. et al. 2017. Psychoeducational interventions in adolescent depression: A systematic review. Patient Education and Counseling (10.1016/j.pec.2017.10.015)
Beyer, S. 2017. Economic impact of inclusion in the open labour market for persons with disabilities. Éditions universitaires européennes.
Beyer, S. and Beyer, A. 2017. A systematic review of the literature on the benefits for employers of employing people with learning disabilities. Technical Report.
Bhugra, D. et al., 2017. The WPA-Lancet Psychiatry Commission on the future of psychiatry. The Lancet Psychiatry 4 (10), pp.775-818. (10.1016/S2215-0366(17)30333-4)
Bigdeli, T. B. et al., 2017. Genetic effects influencing risk for major depressive disorder in China and Europe. Translational Psychiatry 7 (3), pp.e1074. (10.1038/tp.2016.292)
Blokland, G. A. M. et al., 2017. Heritability of neuropsychological measures in Schizophrenia and non-psychiatric populations: a systematic review and meta-analysis. Schizophrenia Bulletin 43 (4), pp.788-800. (10.1093/schbul/sbw146)
Bowles, K. R. et al. 2017. SMAD transcription factors are altered in cell models of HD and regulate HTT expression. Cellular Signalling 31 , pp.1-14. (10.1016/j.cellsig.2016.12.005)
Casanova Dias, M. et al. 2017. Equipping doctors for global health challenges. Journal of the Royal Society of Medicine 110 (1), pp.5-8. (10.1177/0141076816686349)
Chao, M. J. et al., 2017. Haplotype-based stratification of Huntington's disease. European Journal of Human Genetics 25 , pp.1202-1209. (10.1038/ejhg.2017.125)
Charney, A. W. et al., 2017. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Translational Psychiatry 7 (1), pp.e993. (10.1038/tp.2016.242)
Chawner, S. et al. 2017. Childhood cognitive development in 22q11.2 deletion syndrome: case–control study. British Journal of Psychiatry 211 (4), pp.223-230. (10.1192/bjp.bp.116.195651)
Clifton, N. E. et al. 2017. Schizophrenia copy number variants and associative learning. Molecular Psychiatry 22 (2), pp.178-182. (10.1038/mp.2016.227)
Connolly, S. et al., 2017. A genome-wide investigation into parent-of-origin effects in autism spectrum disorder identifies previously associated genes including SHANK3. European Journal of Human Genetics 25 (2), pp.234-239. (10.1038/ejhg.2016.153)
Copeland, L. et al. 2017. Measurement of side effects of anti-epileptic drugs (AEDs) in adults with intellectual disability: A systematic review. Seizure - European Journal of Epilepsy 51 , pp.61-73. (10.1016/j.seizure.2017.07.013)
Cosgrove, D. et al., 2017. MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls. Translational Psychiatry 7 (1), pp.e1012. (10.1038/tp.2016.286)
Cosgrove, D. et al., 2017. Cognitive characterization of schizophrenia risk variants involved in synaptic transmission: evidence of CACNA1C's role in working memory. Neuropsychopharmacology 42 , pp.2612-2622. (10.1038/npp.2017.123)
Crawshaw, A. and Harding, K. 2017. A portrait of the brain by Adam Zeman [Book Club]. Practical Neurology 17 , pp.419-419. (10.1136/practneurol-2017-001746)
Crawshaw, A. and Harding, K. 2017. The Selfish Gene. Practical Neurology 17 (3), pp.244. (10.1136/practneurol-2017-001645)
Crawshaw, A. A. and Robertson, N. P. 2017. The role of TSPO PET in assessing neuroinflammation. Journal of Neurology 264 (8), pp.1825-1827. (10.1007/s00415-017-8565-1)
Davies, W. 2017. Understanding the pathophysiology of postpartum psychosis: challenges and new approaches. World Journal of Psychiatry 7 (2), pp.77-88. http://dx.doi.org/10.5498/wjp.v7.i2.77. (10.5498/wjp.v7.i2.77)
De Giglio, L. et al., 2017. Effect on cognition of estroprogestins combined with Interferon beta in multiple sclerosis: analysis of secondary outcomes from a randomized controlled trial. CNS Drugs 31 (2), pp.161-168. (10.1007/s40263-016-0401-0)
Deans, P. J. M. et al., 2017. Psychosis risk candidate ZNF804A localizes to synapses and regulates neurite formation and dendritic spine structure. Biological Psychiatry 82 (1), pp.49-61. (10.1016/j.biopsych.2016.08.038)
Demaerel, W. et al., 2017. Nested inversion polymorphisms predispose chromosome 22q11.2 to meiotic rearrangements [RETRACTED]. American Journal of Human Genetics 101 (4), pp.616-622. (10.1016/j.ajhg.2017.09.002)
Di Florio, A. et al. 2017. The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. Psychological Medicine 47 (5), pp.787-799. (10.1017/S0033291716002087)
Dimitriadis, S. 2017. A high performing EEG approach for the automated scoring of the sleep stages of neonates. Clinical Neurophysiology 128 (6), pp.1039-1040. (10.1016/j.clinph.2017.04.001)
Dimitriadis, S. et al. 2017. Data-driven topological filtering based on orthogonal minimal spanning trees: application to multi-group MEG resting-state connectivity. Brain Connectivity 7 (10), pp.661-670. (10.1089/brain.2017.0512)
Dimitriadis, S. et al. 2017. Topological filtering of dynamic functional brain networks unfolds informative chronnectomics: a novel data-driven thresholding scheme based on Orthogonal Minimal Spanning Trees (OMSTs). Frontiers in Neuroinformatics 11 28. (10.3389/fninf.2017.00028)
Direk, N. et al., 2017. An analysis of two genome-wide association meta-analyses identifies a new locus for broad depression phenotype. Biological Psychiatry 82 (5), pp.322-329. (10.1016/j.biopsych.2016.11.013)
Escott-Price, V. and Jones, L. 2017. Genomic profiling and diagnostic biomarkers in Alzheimer's disease. The Lancet Neurology 16 (8), pp.582-583. (10.1016/S1474-4422(17)30202-8)
Escott-Price, V. et al. 2017. Polygenic risk score analysis of pathologically confirmed Alzheimer's disease. Annals of Neurology 82 (2), pp.311-314. (10.1002/ana.24999)
Escott-Price, V. et al. 2017. Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease. Neurobiology of Aging 49 , pp.214.e7-214.e11. (10.1016/j.neurobiolaging.2016.07.018)
Eyre, O. et al. 2017. Irritability in ADHD: Associations with depression liability. Journal of Affective Disorders 215 , pp.281-287. (10.1016/j.jad.2017.03.050)
Fabbri, C. et al., 2017. Consensus paper of the WFSBP Task Force on Genetics: genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response. World Journal of Biological Psychiatry 18 (1), pp.5-28. (10.1080/15622975.2016.1208843)
Ferguson, E. H. et al., 2017. HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression. Archives of Women's Mental Health 20 (3), pp.411-420. (10.1007/s00737-017-0716-y)
Fernández, E. et al., 2017. Arc requires PSD95 for assembly into postsynaptic complexes involved with neural dysfunction and intelligence. Cell Reports 21 (3), pp.679-691. (10.1016/j.celrep.2017.09.045)
Fonferko-Shadrach, B. et al., 2017. Validating epilepsy diagnoses in routinely collected data. Seizure 52 , pp.195-196. (10.1016/j.seizure.2017.10.008)
Fovet, T. et al., 2017. Serious games: the future of psychotherapy? proposal of an integrative model. Psychotherapy and Psychosomatics 86 (3), pp.187-188. (10.1159/000460256)
Fraguas, D. et al., 2017. Mental disorders of known aetiology and precision medicine in psychiatry: a promising but neglected alliance [Editorial]. Psychological Medicine 47 (2), pp.193-197. (10.1017/S0033291716001355)
Gage, S. H. et al., 2017. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychological Medicine 47 (5), pp.971-980. (10.1017/S0033291716003172)
Gage, S. H. et al., 2017. Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization. Scientific Reports 7 40653. (10.1038/srep40653)
García-González, J. et al., 2017. Pharmacogenetics of antidepressant response: a polygenic approach. Progress in Neuro-Psychopharmacology and Biological Psychiatry 75 , pp.128-134. (10.1016/j.pnpbp.2017.01.011)
Giegling, I. et al., 2017. Genetics of schizophrenia: A consensus paper of the WFSBP task force on genetics. World Journal of Biological Psychiatry 18 (7), pp.492-505. (10.1080/15622975.2016.1268715)
Gomes, C. et al., 2017. Phenotyping the ancient world: the physical appearance and ancestry of very degraded samples from a chalcolithic human remains. Forensic Science International: Genetics Supplement Series 6 , pp.e484-e486. (10.1016/j.fsigss.2017.09.188)
Gordon-Smith, K. et al., 2017. Changes to the diagnostic criteria for bipolar disorder in DSM-5 make little difference to lifetime diagnosis: findings from the U.K. Bipolar Disorder Research Network (BDRN) study. American Journal of Psychiatry 174 (8), pp.803. (10.1176/appi.ajp.2017.17010109)
Green, E. K. et al., 2017. Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar type. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174 (8), pp.767-771. (10.1002/ajmg.b.32572)
Green, T. , Naylor, P. and Davies, W. 2017. Attention Deficit Hyperactivity Disorder (ADHD) in phenotypically-similar neurogenetic conditions: Turner syndrome and the RASopathies. Journal of Neurodevelopmental Disorders 9 (25), pp.794-802. (10.1186/s11689-017-9205-x)
Greene, C. et al., 2017. Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Molecular Psychiatry 23 , pp.2156-2166. (10.1038/mp.2017.156)
Grütz, K. et al., 2017. Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia. Scientific Reports 7 41156. (10.1038/srep41156)
Gur, R. et al., 2017. A neurogenetic model for the study of schizophrenia spectrum disorders: The International 22q11.2 Deletion Syndrome Brain Behavior Consortium. Molecular Psychiatry 22 , pp.1664-1672.
Gutierrez, F. et al., 2017. Psychometric properties of the Spanish PID-5 in a clinical and a community sample. Assessment 24 (3), pp.326-336. (10.1177/1073191115606518)
Hakobyan, S. et al. 2017. Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal 23 (7), pp.946-955. 135245851666900. (10.1177/1352458516669002)
Hampel, H. et al., 2017. A precision medicine initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling. Climacteric 20 (2), pp.107-118. (10.1080/13697137.2017.1287866)
Handley, J. D. et al., 2017. On the road again: assessing driving ability in patients with neurological conditions. Practical Neurology 17 (3)(10.1136/practneurol-2017-001601)
Hannon, E. et al., 2017. Pleiotropic effects of trait-associated genetic variation on DNA methylation: utility for refining GWAS loci. American Journal of Human Genetics 100 (6), pp.954-959. (10.1016/j.ajhg.2017.04.013)
Harding, K. and Robertson, N. 2017. Epidemiology of progressive multiple sclerosis. In: Wilkins, A. ed. Progressive Multiple Sclerosis. Springer. , pp.31-47. (10.1007/978-3-319-65921-3_2)
Harding, K. et al. 2017. Seasonal variation in multiple sclerosis relapse. Journal of Neurology 264 (6), pp.1059-1067. (10.1007/s00415-017-8485-0)
Harrison, J. R. 2017. Improving inpatient care for older adults: implementing dementia commissioning for quality and innovation (CQUIN). BMJ Quality Improvement Reports 6 (1), pp.u212202.w4875. (10.1136/bmjquality.u212202.w4875)
Harvey, E. et al., 2017. Potency of human cardiosphere-derived cells from patients with ischemic heart disease is associated with robust vascular supportive ability. Stem Cells Translational Medicine 6 (5), pp.1399-1411. (10.1002/sctm.16-0229)
Hayes, J. F. et al., 2017. Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study. Psychological Medicine 47 (1), pp.1-11. (10.1017/S0033291716001574)
Hendricks, A. E. et al., 2017. Rare variant analysis of human and rodent obesity genes in individuals with severe childhood obesity. Scientific Reports 7 4394. (10.1038/s41598-017-03054-8)
Hensman Moss, D. J. et al., 2017. Huntington's disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer's disease. Scientific Reports 7 , pp.-. 44849. (10.1038/srep44849)
Hensman Moss, D. J. et al., 2017. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. Lancet Neurology 16 (9), pp.701-711. (10.1016/S1474-4422(17)30161-8)
Hill, M. et al. 2017. Knockdown of the schizophrenia susceptibility gene TCF4 alters gene expression and proliferation of progenitor cells from the developing human neocortex. Journal of Psychiatry & Neuroscience 42 (3), pp.181-188. 160073. (10.1503/jpn.160073)
Holmans, P. A. , Massey, T. H. and Jones, L. 2017. Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders. Human Molecular Genetics 26 (R2), pp.R83-R90. (10.1093/hmg/ddx261)
Howes, O. D. et al., 2017. The role of genes, stress, and dopamine in the development of schizophrenia. Biological psychiatry 81 (1), pp.9-20. (10.1016/j.biopsych.2016.07.014)
Hrastelj, J. and Robertson, N. 2017. Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies. Journal of Neurology 264 (9), pp.2040-2042. (10.1007/s00415-017-8584-y)
Huang, A. Y. et al., 2017. Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette Syndrome. Neuron 94 (6), pp.1101-1111.e7. (10.1016/j.neuron.2017.06.010)
Huang, K. et al., 2017. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease. Nature Neuroscience 20 (8), pp.1052-1061. (10.1038/nn.4587)
Hughes, E. and Thomas, R. H. 2017. Epilepsy treatment priorities: answering the questions that matter. Journal of Neurology, Neurosurgery, and Psychiatry 88 (11), pp.999-1001. (10.1136/jnnp-2016-315135)
Humby, T. et al. 2017. A genetic variant within STS previously associated with inattention in boys with Attention Deficit Hyperactivity Disorder is associated with enhanced cognition in healthy adult males. Brain and Behavior 7 (3) e00646. (10.1002/brb3.646)
Hyland, P. et al., 2017. Validation of Posttraumatic Stress Disorder (PTSD) and Complex-PTSD using the International Trauma Questionnaire. Acta Psychiatrica Scandinavica 136 (3), pp.313-322. (10.1111/acps.12771)
Jamjoom, A. A. B. et al., 2017. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. Journal of Neurology, Neurosurgery & Psychiatry (10.1136/jnnp-2017-316415)
Jansen, I. E. et al., 2017. Establishing the role of rare coding variants in known Parkinson's disease risk loci. Neurobiology of Aging 59 , pp.220.e11-220.e18. (10.1016/j.neurobiolaging.2017.07.009)
Jeong, Y. H. et al., 2017. Tdp-43 cryptic exons are highly variable between cell types. Molecular Neurodegeneration 12 (10.1186/s13024-016-0144-x)
Johnston, H. R. et al., 2017. PEMapper and PECaller provide a simplified approach to whole-genome sequencing. Proceedings of the National Academy of Sciences of the United States of America 114 (10), pp.E1923-E1932. (10.1073/pnas.1618065114)
Jones, L. , Houlden, H. and Tabrizi, S. J. 2017. DNA repair in the trinucleotide repeat disorders. The Lancet Neurology 16 (1), pp.88-96. (10.1016/S1474-4422(16)30350-7)
Jones, L. and Robertson, N. 2017. An update on treatments in myasthenia gravis. Journal of Neurology 264 (1), pp.205-207. (10.1007/s00415-016-8359-x)
Jones, L. and Thomas, R. H. 2017. Sudden death in epilepsy: insights from the last 25 years. Seizure - European Journal of Epilepsy 44 , pp.232-236. (10.1016/j.seizure.2016.10.002)
Joneson, S. and O'Brien, H. 2017. A molecular investigation of free-living and lichenized Nostoc sp. and symbiotic lifestyle determination. The Bryologist 120 (4), pp.371-381. (10.1639/0007-2745-120.4.371)
Kalincik, T. et al., 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. Lancet Neurology 16 (4), pp.271-281. (10.1016/S1474-4422(17)30007-8)
Kanemoto, K. et al., 2017. PNES around the world: where we are now and how we can close the diagnosis and treatment gaps. An ILAE PNES Task Force report. Epilepsia Open 2 (3), pp.307-316. (10.1002/epi4.12060)
Karatzias, T. et al., 2017. Evidence of distinct profiles of Posttraumatic Stress Disorder (PTSD) and Complex Posttraumatic Stress Disorder (CPTSD) based on the new ICD-11 Trauma Questionnaire (ICD-TQ). Journal of Affective Disorders 207 , pp.181-187. (10.1016/j.jad.2016.09.032)
Kendall, K. M. et al. 2017. Cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK Biobank subjects. Biological Psychiatry 82 (2), pp.P103-110. (10.1016/j.biopsych.2016.08.014)
Kerr, M. P. and Joshi, N. 2017. Epilepsy and intellectual disability. In: Krishnamoorthy, E. S. and Shorvon, S. eds. Epiliepsy: A Global Approach. 9781139547918 Cambridge: Cambridge University Press. , pp.185-188. (10.1017/9781139547918.041)
Keynejad, R. C. et al., 2017. Docbate: a National Medical Student Debate. Academic Psychiatry 41 (6), pp.839-841. (10.1007/s40596-017-0697-1)
Kirkwood, N. K. et al., 2017. d-Tubocurarine and berbamine: alkaloids that are permeant blockers of the hair cell's mechano-electrical transducer channel and protect from aminoglycoside toxicity. Frontiers in Cellular Neuroscience 11 262. (10.3389/fncel.2017.00262)
Knöchel, C. et al., 2017. Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience 267 (3), pp.199-212. (10.1007/s00406-016-0724-3)
Kun-Rodrigues, C. et al., 2017. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiology of Aging 49 , pp.214.e13-214.e15. (10.1016/j.neurobiolaging.2016.08.023)
Lancaster, T. et al. 2017. Further support for association between GWAS variant for positive emotion and reward systems. Translational Psychiatry 7 (1) e1018. (10.1038/tp.2016.289)
Lara-Cinisomo, S. et al., 2017. Associations between postpartum depression, breastfeeding, and oxytocin levels in Latina mothers. Breastfeeding Medicine 12 (7), pp.436-442. (10.1089/bfm.2016.0213)
Lee, J. et al., 2017. A modifier of Huntington's disease onset at the MLH1 locus. Human Molecular Genetics 26 (19), pp.3859-3867. (10.1093/hmg/ddx286)
Legge, S. E. et al. 2017. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Molecular Psychiatry 22 , pp.1502-1508. (10.1038/mp.2016.97)
Leonenko, G. et al. 2017. Investigation of relationships between bipolar disorder phenotypes and genome-wide significant loci from PGC2 schizophrenia. European Neuropsychopharmacology 27 (S3), pp.S383-S384. (10.1016/j.euroneuro.2016.09.416)
Leonenko, G. et al. 2017. Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174 (7), pp.724-731. (10.1002/ajmg.b.32560)
Lewis, C. et al. 2017. Internet-based guided self-help for post-traumatic stress disorder (PTSD): randomised controlled trial. Depression and Anxiety 34 (6), pp.555-565. (10.1002/da.22645)
Lewis, C. et al. 2017. Trauma exposure and undetected Post-Traumatic Stress Disorder (PTSD) among adults with a mental disorder. Depression and Anxiety 35 (2), pp.178-184. (10.1002/da.22707)
Lewis, J. T. et al. 2017. Cardiff sciSCREEN: A model for using film screenings to engage publics in University research. Research for All 1 (1), pp.106-120. (10.18546/RFA.01.1.08)
Lewis, K. et al. 2017. Sleep loss as a trigger of mood episodes in bipolar disorder: individual differences based on diagnostic subtype and gender. British Journal of Psychiatry 211 (3), pp.169-174. (10.1192/bjp.bp.117.202259)
Li, M. and Rosser, A. E. 2017. Pluripotent stem cell-derived neurons for transplantation in Huntington's disease. In: Howard, C. J. ed. Functional Neural Transplantation. Progress in Brain Research Elsevier. , pp.263-281. (10.1016/bs.pbr.2017.02.009)
Li, Z. et al., 2017. Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. Nature Genetics 49 , pp.1576-1583. (10.1038/ng.3973)
Lo, M. et al., 2017. Genome-wide analyses for personality traits identify six genomic loci and show correlations with psychiatric disorders. Nature Genetics 49 , pp.152-156. (10.1038/ng.3736)
Lopez, B. et al., 2017. Treponemal disease in the Old World? Integrated paleopathological assessment of a 9th-11th century skeleton from North-Central Spain. Anthropological Science 125 (2), pp.101-114. (10.1537/ase.170515)
Mackay, D. et al., 2017. Exposure to tobacco smoke in utero or during early childhood and risk of hypomania: prospective birth cohort study. European Psychiatry 39 , pp.33-39. (10.1016/j.eurpsy.2016.06.001)
Malek, N. et al., 2017. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases. Parkinsonism & Related Disorders 40 , pp.40-46. (10.1016/j.parkreldis.2017.04.006)
Malik, A. et al., 2017. X-linked ichthyosis associated with psychosis and behavioral abnormalities: a case report. Journal of Medical Case Reports 11 267. (10.1186/s13256-017-1420-2)
Malik, G. A. and Robertson, N. P. 2017. Treatments in Alzheimer's disease. Journal of Neurology 264 (2), pp.416-418. (10.1007/s00415-017-8395-1)
Malki, K. et al., 2017. Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174 (3), pp.235-250. (10.1002/ajmg.b.32494)
Marshall, C. R. et al., 2017. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nature Genetics 49 , pp.27-35. (10.1038/ng.3725)
Massey, T. and Robertson, N. 2017. Why antisense could make sense for neurodegeneration. Journal of Neurology 264 (7), pp.1542-1544. (10.1007/s00415-017-8515-y)
Massey, T. et al. 2017. Rescue of severe brain and cervical cord IRIS by restarting natalizumab in a pregnant MS patient. Neurology 88 (7), pp.711-713. (10.1212/WNL.0000000000003604)
McLauchlan, D. , Malik, G. A. and Robertson, N. P. 2017. Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment. Journal of Neurology 264 , pp.2184-2186. (10.1007/s00415-017-8608-7)
McLauchlan, D. and Robertson, N. P. 2017. B cell treatments for multiple sclerosis. Journal of Neurology 264 (4), pp.814-816. (10.1007/s00415-017-8442-y)
McLaughlin, R. L. et al., 2017. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications 8 14774. (10.1038/ncomms14774)
Mehler, D. M. A. et al. 2017. Minimizing endpoint variability through reinforcement learning during reaching movements involving shoulder, elbow and wrist. PLoS ONE 12 (7) e0180803. (10.1371/journal.pone.0180803)
Meyer, E. et al., 2017. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. Nature Genetics 49 , pp.223-237. (10.1038/ng.3740)
Mihaljevic, M. et al., 2017. The emerging role of the FKBP5 gene polymorphisms in vulnerability-stress model of schizophrenia: further evidence from a Serbian population. European Archives of Psychiatry and Clinical Neuroscience 267 (6), pp.527-539. (10.1007/s00406-016-0720-7)
Mistry, S. et al. 2017. Borderline personality and attention-deficit hyperactivity traits in childhood are associated with hypomanic features in early adulthood. Journal of affective disorders 221 , pp.246-253. (10.1016/j.jad.2017.06.039)
Morgan, A. et al. 2017. The correlation between inflammatory biomarkers and polygenic risk score in Alzheimer's Disease. Journal of Alzheimer's Disease 56 (1), pp.25-36. (10.3233/JAD-160889)
Munoz Solomando, A. and Thapar, A. 2017. Attention Deficit Hyperactivity Disorder. In: Skuse, D. , Bruce, H. and Dowdney, L. eds. Child Psychology and Psychiatry: Frameworks for Clinical Training and Practice. Wiley. , pp.203-214.
Neilson, E. et al., 2017. Effects of environmental risks and polygenic loading for schizophrenia on cortical thickness. Schizophrenia Research 184 , pp.128-136. (10.1016/j.schres.2016.12.011)
Niarchou, M. et al. 2017. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome. Journal of Psychiatric Research 92 , pp.124-131. (10.1016/j.jpsychires.2017.04.006)
Noe, B. et al. 2017. Timing rather than user traits mediates mood sampling on smartphones. BMC Research Notes 10 481. (10.1186/s13104-017-2808-1)
O'Gorman, A. et al., 2017. Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. Translational Psychiatry 7 (9) e1240. (10.1038/tp.2017.211)
Peall, K. et al. 2017. Low CSF 5-HIAA in myoclonus dystonia. Movement Disorders 32 (11), pp.1647-1649. (10.1002/mds.27117)
Peall, K. J. et al. 2017. A review of psychiatric co-morbidity described in genetic and immune mediated movement disorders. Neuroscience & Biobehavioral Reviews 80 , pp.23-35. (10.1016/j.neubiorev.2017.05.014)
Pedroso, J. L. et al., 2017. The relationship between the First World War and neurology: 100 years of "Shell Shock". Arquivos de Neuro-Psiquiatria 75 (5), pp.317. (10.1590/0004-282x20170046)
Perry, A. et al., 2017. A visual timeline tool for tracking mood and medication perinatally in affective disorders. Archives of Women's Mental Health 20 (5), pp.709-710. (10.1007/s00737-017-0743-8)
Petit, E. I. et al., 2017. Dysregulation of specialized delay/interference-dependent working memory following loss of Dysbindin-1A in schizophrenia-related phenotypes. Neuropsychopharmacology 42 (6), pp.1349-1360. (10.1038/npp.2016.282)
Phillips, T. J. et al., 2017. Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development. Scientific Reports 7 , pp.-. 9079. (10.1038/s41598-017-06300-1)
Pickrell, W. O. and Robertson, N. P. 2017. Cannabidiol as a treatment for epilepsy. Journal of Neurology 264 (12), pp.2506-2508. (10.1007/s00415-017-8663-0)
Polimanti, R. et al., 2017. A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder. Genome Medicine 9 99. (10.1186/s13073-017-0491-4)
Precious, S. V. et al., 2017. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?. Neurochemistry International 106 , pp.114-121. (10.1016/j.neuint.2017.01.016)
Putnam, K. T. et al., 2017. Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. The Lancet Psychiatry 4 (6), pp.477-485. (10.1016/S2215-0366(17)30136-0)
Rice, F. et al. 2017. Adolescent depression and the treatment gap. The Lancet Psychiatry 4 (2), pp.86-87. (10.1016/S2215-0366(17)30004-4)
Rice, F. et al. 2017. Antecedents of new-onset major depressive disorder in children and adolescents at high familial risk. JAMA Psychiatry 74 (2), pp.153-160. (10.1001/jamapsychiatry.2016.3140)
Richards, G. , Bellin, W. and Davies, W. 2017. Familial digit ratio (2D:4D) associations in a general population sample from Wales. Early Human Development 112 , pp.14-19. (10.1016/j.earlhumdev.2017.06.006)
Rietschel, L. et al., 2017. Hair cortisol in twins: Heritability and genetic overlap with psychological variables and stress-system genes. Scientific Reports 7 (1) 15351. (10.1038/s41598-017-11852-3)
Riglin, L. et al. 2017. Schizophrenia polygenic risk score and psychotic risk detection - authors' reply. The Lancet Psychiatry 4 (3), pp.188-189. (10.1016/S2215-0366(17)30052-4)
Riglin, L. et al. 2017. Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study. Lancet Psychiatry 4 (1), pp.57-62. (10.1016/S2215-0366(16)30406-0)
Riglin, L. et al. 2017. Investigating the genetic underpinnings of early-life irritability. Translational Psychiatry 7 e1241. (10.1038/tp.2017.212)
Rivera, M. et al., 2017. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. British Journal of Psychiatry 211 (2), pp.70-76. (10.1192/bjp.bp.116.183475)
Robertson, N. and Peall, K. J. 2017. Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms. Journal of Neurology 264 (3), pp.616-618. (10.1007/s00415-017-8411-5)
Schmaal, L. et al., 2017. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Molecular Psychiatry 22 (6), pp.900-909. (10.1038/mp.2016.60)
Schnyder, U. et al., 2017. The global collaboration on traumatic stress. European Journal of Psychotraumatology 8 (sup7) 1403257. (10.1080/20008198.2017.1403257)
Shevlin, M. et al., 2017. Alternative models of disorders of traumatic stress based on the new ICD-11 proposals. Acta Psychiatrica Scandinavica 135 (5), pp.419-428. (10.1111/acps.12695)
Shevlin, M. et al., 2017. Examining the disconnect between psychometric models and clinical reality of posttraumatic stress disorder. Journal of Anxiety Disorders 47 , pp.54-59. (10.1016/j.janxdis.2017.02.006)
Sims, R. et al. 2017. Rare coding variants in PLCG2, ABI3 and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics 49 , pp.1373-1384. (10.1038/ng.3916)
Singh, T. et al., 2017. The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nature Genetics 49 , pp.1167-1173. (10.1038/ng.3903)
Smith, P. and Thomas, R. 2017. Phenotypic analysis of 303 multiplex families with common epilepsies. Brain 140 (8), pp.2144-2156. (10.1093/brain/awx129)
Spiers, H. et al., 2017. 5-hydroxymethylcytosine is highly dynamic across human fetal brain development. BMC Genomics 18 , pp.738. (10.1186/s12864-017-4091-x)
St Pourcain, B. et al., 2017. ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Molecular Psychiatry 23 , pp.263-270. (10.1038/mp.2016.198)
Stanfield, A. M. et al., 2017. Dissociation of brain activation in autism and schizotypal personality disorder during social judgements. Schizophrenia Bulletin 43 (6), pp.1220-1228. (10.1093/schbul/sbx083)
Stergiakouli, E. et al., 2017. Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development. Molecular Autism 8 18. (10.1186/s13229-017-0131-2)
Stergiakouli, E. et al., 2017. Association between polygenic risk scores for attention-deficit hyperactivity disorder and educational and cognitive outcomes in the general population. International Journal of Epidemiology 46 (2), pp.421-428. (10.1093/ije/dyw216)
Stergiakouli, E. , Thapar, A. and Davey Smith, G. 2017. Acetaminophen in pregnancy and adverse childhood neurodevelopment-reply. JAMA Pediatrics 171 (4)(10.1001/jamapediatrics.2016.5040)
Stuart-Smith, J. et al. 2017. Childhood hyperactivity and mood problems at mid-life: evidence from a prospective birth cohort. Social Psychiatry and Psychiatric Epidemiology 52 (1), pp.87-94. (10.1007/s00127-016-1285-5)
Sullivan, P. F. et al., 2017. Psychiatric genomics: an update and an agenda. American Journal of Psychiatry 175 (1), pp.15-27. (10.1176/appi.ajp.2017.17030283)
Sullivan, S. A. et al., 2017. The longitudinal association between external locus of control, social cognition and adolescent psychopathology. Social Psychiatry and Psychiatric Epidemiology 52 (6), pp.643-655. (10.1007/s00127-017-1359-z)
Summers, M. et al. 2017. BRAF and NRAS locus-specific variants have different outcomes on survival to colorectal cancer. Clinical Cancer Research 23 (11), pp.2742-2749. (10.1158/1078-0432.CCR-16-1541)
Thapar, A. 2017. Intellectual disability and attention-deficit/hyperactivity disorder: What does the clinical and genetic overlap mean for practice and research?. Journal of the American Academy of Child & Adolescent Psychiatry 56 (2), pp.105-106. (10.1016/j.jaac.2016.11.012)
Thapar, A. , Cooper, M. and Rutter, M. 2017. Neurodevelopmental disorders. The Lancet Psychiatry 4 (4), pp.339-346. (10.1016/S2215-0366(16)30376-5)
The Autism Spectrum Disorders Working Group of The Psychiatric G, , Anney, R. J. L. and Holmans, P. 2017. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Molecular Autism 8 21. (10.1186/s13229-017-0137-9)
Thomas, R. 2017. Ultra-rare genetic variation in common epilepsies: a case-control sequencing study. Lancet Neurology 16 (2), pp.135-143. (10.1016/S1474-4422(16)30359-3)
Trent, S. et al. 2017. AMPA receptors control fear extinction through an Arc-dependent mechanism. Learning and Memory 24 , pp.375-380. (10.1101/lm.045013.117)
Uhlhaas, P. J. et al., 2017. Magnetoencephalography as a tool in psychiatric research: current status and perspective. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2 (3), pp.235-244. (10.1016/j.bpsc.2017.01.005)
van de Ven, V. et al., 2017. Reduced intrinsic visual cortical connectivity is associated with impaired perceptual closure in schizophrenia. NeuroImage: Clinical 15 , pp.45-52. (10.1016/j.nicl.2017.04.012)
van de Zande, N. A. et al., 2017. Clinical characterization of dystonia in adult patients with Huntington's disease. European Journal of Neurology 24 (9), pp.1140-1147. (10.1111/ene.13349)
Vorstman, J. A. S. et al., 2017. Autism genetics: opportunities and challenges for clinical translation. Nature Reviews Genetics 18 (6), pp.362-376. (10.1038/nrg.2017.4)
Ward, J. et al., 2017. Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with MDD, anxiety disorder and schizophrenia. Translational Psychiatry 7 1264. (10.1038/s41398-017-0012-7)
Weiner, D. J. et al., 2017. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nature Genetics 49 (7), pp.978-985. (10.1038/ng.3863)
Weisman, O. et al., 2017. Lithium use in pregnancy and the risk of cardiac malformations. New England Journal of Medicine 377 (9), pp.893-894. (10.1056/NEJMc1708919)
Weisman, O. et al., 2017. Subthreshold psychosis in 22q11.2 deletion syndrome: multisite naturalistic study. Schizophrenia Bulletin 43 (5), pp.1079-1089. (10.1093/schbul/sbx005)
Welton, J. L. et al., 2017. Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis. Journal of Extracellular Vesicles 6 (1) 1369805. (10.1080/20013078.2017.1369805)
Willis, M. et al. 2017. An observational study of alemtuzumab following fingolimod for multiple sclerosis. Neuroimmunology and Neuroinflammation 4 (2) E320. (10.1212/NXI.0000000000000320)
Willis, M. D. and Robertson, N. P. 2017. Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis. Journal of Neurology 264 (6), pp.1298-1300. (10.1007/s00415-017-8508-x)
Witt, S. H. et al., 2017. Genome-wide association study of borderline personality disorder reveals genetic overlap with the bipolar disorder, schizophrenia and major depression. Translational Psychiatry 7 e1155.
Wynford-Thomas, R. and Robertson, N. 2017. The economic burden of chronic neurological disease. Journal of Neurology 264 (11), pp.2345-2347. (10.1007/s00415-017-8632-7)
Xiao, J. et al., 2017. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome. Neurobiology of Disease 98 , pp.52-65. (10.1016/j.nbd.2016.11.003)
Yhnell, E. 2017. Huntington's disease: of mice and men. Oncotarget 8 (8), pp.12552-12553. (10.18632/oncotarget.15129)

2017 publications

Archif cyhoeddiadau

Canolfan ar gyfer Geneteg a Genomeg Niwroseiciatrig

Cysylltwch â ni

Ymweld â Chanolfan ar gyfer Geneteg a Genomeg Niwroseiciatrig